当前位置: 首页 > 期刊 > 《右江医学》 > 2019年第1期
编号:13326543
CD44和LRP表达与前列腺腺癌发病风险的研究(3)
http://www.100md.com 2019年2月1日 《右江医学》 2019年第1期
     [16]Appert-Collin A,Bennasroune A,Jeannesson P,et al.Role of LRP-1 in cancer cell migration in 3-dimensional collagen matrix[J].Cell Adh Migr,2017,11(4):316-326.

    [17]Ling Lin,Kebin Hu.LRP-1:Functions,Signaling and Implications in Kidney and Other Diseases[J].Int J Mol Sci,2014,15(12):22887-22901.

    [18]Louis Theret,Albin Jeanne,Benoit Langlois,et al.Identification of LRP-1 as an endocytosis and recycling receptor for β1-integrin in thyroid cancer cells[J].Oncotarget,2017,8(45):78614-78632.

    [19]Li X,Lv L,Zheng J,et al.The significance of LRPPRC overexpression in gastric cancer[J].Med Oncol,2014,31(2):818.

    [20]Jiang X,Li X,Huang H,et al.Elevated levels of mitochondrion associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer[J].Cancer,2014,120(8):1228-1236.

    [21]Kluth M,Galal R,Krohn A,et al.Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer[J].Int J Oncol,2015,46(4):1637-1642.

    [22]Zhang HY,Ma YD,Zhang Y,et al.Elevated levels of autophagy-related marker ULK1 and mitochondrion-associated autophagy inhibitor LRPPRC are associated with biochemical progression and overall survival after androgen deprivation therapy in patients with metastatic prostate cancer[J].J Clin Pathol,2017,70(5):383-389.

    (收稿日期:2018-11-09修回日期:2019-01-07)

    (編辑:潘明志), http://www.100md.com(马凤艳 黄炳臣 黄小英)
上一页1 2 3